GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING Trademark
Trademark Overview
On Thursday, October 5, 2023, a trademark application was filed for GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING with the United States Patent and Trademark Office. The USPTO has given the GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING trademark a serial number of 98211364. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 13, 2024. This trademark is owned by Oncocyte Corporation. The GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING trademark is filed in the Pharmaceutical Products category with the following description:
Research use only transplant test kits using digital polymerase chain reaction technology to measure and test the concentration of donor-derived cell free DNA in a single nucleotide polymorphism gene; test kits for use in measuring DNA levels for transplant research purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation
General Information
| Serial Number | 98211364 |
| Word Mark | GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING |
| Filing Date | Thursday, October 5, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, August 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 18, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the wording "Graft" followed by "Assure" separated by a double helix design, stacked over the wording "dd-cfDNA Transplant Monitoring" in smaller size font. |
| Goods and Services | Research use only transplant test kits using digital polymerase chain reaction technology to measure and test the concentration of donor-derived cell free DNA in a single nucleotide polymorphism gene; test kits for use in measuring DNA levels for transplant research purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in transplantation monitoring and transplantation therapy evaluation |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | DD-CFDNA and TRANSPLANT MONITORING |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 14, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Oncocyte Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
| Party Name | Oncocyte Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
Trademark Events
| Event Date | Event Description |
| Saturday, October 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 9, 2023 | NEW APPLICATION ENTERED |
| Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 17, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, April 5, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, April 5, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, April 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 29, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 18, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 18, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
